Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

General Motors Company (GM), Microsoft Corporation (MSFT): How Does This $500 Million Hedge Fund View the Stock Market?

Page 1 of 2

Akanthos Capital is a mid-sized $500+ million hedge fund run by former Goldman derivatives trader, Michael Kao.  Kao holds a degree in computer science and engineering from Berkeley and an MBA from Wharton.  Give the pedigree of the manager, it’s easy to expect his top five stock picks to be equally as impressive. Kao doesn’t hold a particularly large percentage of his assets in stocks—about 7% worth—though it’s crucial to take a look at his equity investments to gauge which sectors of the economy he’s most bullish on. Many of your peers have already capitalized on the market-beating track record of our hedge fund strategies; learn how to do it yourself.

General Motors Company (NYSE:GM)

Topping the list is General Motors Company (NYSE:GM), in which Akanthos owns 600,000 shares.  The stock has put in an uninspiring performance this year, rising only 0.8% since the first of the year.  GM recently reported sales were up 3.6% for the 1Q of 2013 compared to the same period last year.  Although sales of the Chevrolet brand were still rather anemic (+1.0%), the gain came amid a lingering economic slump in Europe.  General Motors Company (NYSE:GM) is trying to beef up demand for Chevrolet in Europe to offset waning demand in the US.  Earnings for the most recent quarter fell to -$0.48 from +$0.93 from 3Q and net income fell 32%.  But looking forward, earnings for the 1Q of 2013 are expected to improve to +$0.59 with revenues to remain relatively flat.

At number two is American International Group Inc (NYSE:AIG), the international insurance company with a $58.4 billion market cap, and a new addition to the hedgie’s equity portfolio with 202,400 shares.  The federal bailout of AIG in 2009 inspired the not-so-endearing moniker “Too Big to Fail.” But American International Group Inc (NYSE:AIG) has actually managed to redeem itself in the years following: it shed much of its non-core businesses and returned to a much more conservative approach to funding its operations.  Although American International Group Inc (NYSE:AIG) will have persistent competition from the other giants of the insurance industry – Hartford, Berkshire Hathaway, Allianz – AIG is priced at 0.6x book value (industry average of 0.9x) with a trailing earnings ratio of 8.7x compared to the sector average of 17.5x.

Third of the top five is Goldcorp Inc. (USA) (NYSE:GG).  Since adding Goldcorp in early 2011, Akanthos’ position has swelled by 11,070%, a true sign of endorsement for the gold producer and a bet by Kao that gold will revisit $1,800 resistance. Unfortunately, the recent plunge in gold prices (down 26% since October 2012) has caused a corresponding 41% drop in the price of Goldcorp Inc. (USA) (NYSE:GG) shares.  And although Goldcorp trades at 10x trailing earnings versus a sector average of 20x, the company saw net income decline $200 million and earnings decline to $1.95 from $2.18.

Fourth on the list is Microsoft Corporation (NASDAQ:MSFT), another new addition to the portfolio with 100,000 shares.  As users begin moving away from the PC and towards smart phones and tablets, Microsoft is looking like a dinosaur in the lightening-paced world of mobile computing.  It doesn’t help that Vista was a major disappointment and Windows 7 came at a time when consumers were strapped for cash at the height of the recession. Fortunately, Microsoft Corporation (NASDAQ:MSFT) leads the pack in cloud computing and servers which is why Morgan Stanley gave the stock a rating of “Overweight.” The stock is up 9% since the start of the year and recently posted a 5-month high of $30.32.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!